复发多发性骨髓瘤局灶性与弥漫性病变在3T全身扩散加权MRI上平均表观扩散系数测量的重复性与重测再现性
前瞻性纳入11例复发多发性骨髓瘤患者,在3T全身扩散加权MRI上对47处病变(23处局灶、24处弥漫)行平均ADC测量;观察者内一致性极好(ICC 0.99,CV 5%),重测再现性极好(ICC 0.916,CV 14.5%),但弥漫病变和小病灶的观察者间一致性差(ICC分别为0.46和0.54)。
要点
- 局灶病变平均ADC测量重复性和再现性好,弥漫病变ADC测量变异较大。
- 观察者间一致性在弥漫病变(ICC 0.46)和小病灶≤10 mm(ICC 0.54)较差。
- 重测ICC在盆腔(0.95)高于胸部(0.81),小病灶(0.96)高于大病灶(0.8)。
核心结论
- 多发性骨髓瘤局灶病变的ADC测量具有重复性和再现性,而弥漫病变的ADC测量变异较大;证据支持ADC测量未来可能作为预测性定量生物标志物。
研究设计与样本
- 经伦理批准的前瞻性研究,纳入11例同意参加的复发多发性骨髓瘤患者,行基线3T全身扩散加权MRI,单一床位置短间隔重复轴位DWI以行重测测量,由两名经验丰富的观察者测量平均ADC。
诊断标准与关键数值
- 共勾画47处病变(23处局灶、24处弥漫),分布于盆腔22处、胸部20处、头颈部5处;观察者内ICC 0.99(0.98-0.99)、CV 5%;观察者间ICC 0.89(0.8-0.934)、CV 17%;弥漫病变观察者间ICC 0.46,小病灶(≤10 mm)观察者间ICC 0.54;重测ICC 0.916、CV 14.5%;重测ICC局灶病变0.83 vs 弥漫浸润0.80,盆腔0.95 vs 胸部0.81,小病灶0.96 vs 大病灶(>10 mm)0.8。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To assess the test-retest reproducibility and intra/interobserver agreement of apparent diffusion coefficient (ADC) measurements of myeloma lesions using whole body diffusion-weighted MRI (WB-DW-MRI) at 3T MRI.
METHODS: Following ethical approval, 11 consenting patients with relapsed multiple myeloma were prospectively recruited and underwent baseline WB-DW-MRI. For a single bed position, axial DWI was repeated after a short interval to permit test-retest measurements.Mean ADC measurement was performed by two experienced observers. Intra- and interobserver agreement and test-retest reproducibility were assessed, using coefficient of variation (CV) and interclass correlation coefficient (ICC) measures, for diffuse and focal lesions (small ≤10 mm and large >10 mm).
RESULTS: 47 sites of disease were outlined (23 focal, 24 diffuse) in different bed positions (pelvis = 22, thorax = 20, head and neck = 5). For all lesions, there was excellent intraobserver agreement with ICC of 0.99 (0.98-0.99) and COV of 5%. For interobserver agreement, ICC was 0.89 (0.8-0.934) and COV was 17%. There was poor interobserver agreement for diffuse disease (ICC = 0.46) and small lesions (ICC = 0.54).For test-retest reproducibility, excellent ICC (0.916) and COV (14.5%) values for mean ADC measurements were observed. ICCs of test-retest were similar between focal lesions (0.83) and diffuse infiltration (0.80), while ICCs were higher in pelvic (0.95) compared to thoracic (0.81) region and in small (0.96) compared to large (0.8) lesions.
CONCLUSION: ADC measurements of focal lesions in multiple myeloma are repeatable and reproducible, while there is more variation in ADC measurements of diffuse disease in patients with multiple myeloma.
ADVANCES IN KNOWLEDGE: Mean ADC measurements are repeatable and reproducible in focal lesions in multiple myeloma, while the ADC measurements of diffuse disease in multiple myeloma are more subject to variation. The evidence supports the future potential role of ADC measurements as predictive quantitative biomarker in multiple myeloma.
引用
- ElGendy, Barwick, Auner, et al. Repeatability and test-retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI). Br J Radiol. 2022. PMID: 35867890. doi:10.1259/bjr.20220418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。